32 related articles for article (PubMed ID: 19138668)
1. Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.
Elsby R; Smith V; Fox L; Stresser D; Butters C; Sharma P; Surry DD
Xenobiotica; 2011 Sep; 41(9):764-83. PubMed ID: 21612343
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications.
Yang Q; Xu J; Gu J; Shi H; Zhang J; Zhang J; Chen ZS; Fang X; Zhu T; Zhang X
Adv Sci (Weinh); 2022 Dec; 9(34):e2201609. PubMed ID: 36253096
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma.
Vieira de Castro J; S Gonçalves C; P Martins E; Miranda-Lorenzo I; T Cerqueira M; Longatto-Filho A; A Pinto A; L Reis R; Sousa N; Heeschen C; M Costa B
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669350
[TBL] [Abstract][Full Text] [Related]
4. Intercellular Vesicular Transfer by Exosomes, Microparticles and Oncosomes - Implications for Cancer Biology and Treatments.
Jaiswal R; Sedger LM
Front Oncol; 2019; 9():125. PubMed ID: 30895170
[TBL] [Abstract][Full Text] [Related]
5. Peroxynitrite and 4-Hydroxynonenal Inactivate Breast Cancer Resistance Protein/ABCG2.
Verenich S; Gerk PM
Biomed Res Int; 2019; 2019():3891535. PubMed ID: 30800667
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles in breast cancer drug resistance and their clinical application.
Yu S; Wei Y; Xu Y; Zhang Y; Li J; Zhang J
Tumour Biol; 2016 Mar; 37(3):2849-61. PubMed ID: 26797784
[TBL] [Abstract][Full Text] [Related]
7. Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.
Miranda-Lorenzo I; Dorado J; Lonardo E; Alcala S; Serrano AG; Clausell-Tormos J; Cioffi M; Megias D; Zagorac S; Balic A; Hidalgo M; Erkan M; Kleeff J; Scarpa A; Sainz B; Heeschen C
Nat Methods; 2014 Nov; 11(11):1161-9. PubMed ID: 25262208
[TBL] [Abstract][Full Text] [Related]
8. From cholesterogenesis to steroidogenesis: role of riboflavin and flavoenzymes in the biosynthesis of vitamin D.
Pinto JT; Cooper AJ
Adv Nutr; 2014 Mar; 5(2):144-63. PubMed ID: 24618756
[TBL] [Abstract][Full Text] [Related]
9. Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics.
Goler-Baron V; Assaraf YG
PLoS One; 2012; 7(4):e35487. PubMed ID: 22530032
[TBL] [Abstract][Full Text] [Related]
10. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.
Natarajan K; Xie Y; Baer MR; Ross DD
Biochem Pharmacol; 2012 Apr; 83(8):1084-103. PubMed ID: 22248732
[TBL] [Abstract][Full Text] [Related]
11. Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers.
Abbas CA; Sibirny AA
Microbiol Mol Biol Rev; 2011 Jun; 75(2):321-60. PubMed ID: 21646432
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance.
Goler-Baron V; Assaraf YG
PLoS One; 2011 Jan; 6(1):e16007. PubMed ID: 21283667
[TBL] [Abstract][Full Text] [Related]
13. Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance.
Ifergan I; Scheffer GL; Assaraf YG
Cancer Res; 2005 Dec; 65(23):10952-8. PubMed ID: 16322243
[TBL] [Abstract][Full Text] [Related]
14. Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
Nakamura Y; Oka M; Soda H; Shiozawa K; Yoshikawa M; Itoh A; Ikegami Y; Tsurutani J; Nakatomi K; Kitazaki T; Doi S; Yoshida H; Kohno S
Cancer Res; 2005 Feb; 65(4):1541-6. PubMed ID: 15735043
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
Doyle L; Ross DD
Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
[TBL] [Abstract][Full Text] [Related]
17. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters.
Hegedüs C; Telbisz Á; Hegedűs T; Sarkadi B; Özvegy-Laczka C
Adv Cancer Res; 2015; 125():97-137. PubMed ID: 25640268
[TBL] [Abstract][Full Text] [Related]
18. Riboflavin concentration within ABCG2-rich extracellular vesicles is a novel marker for multidrug resistance in malignant cells.
Ifergan I; Goler-Baron V; Assaraf YG
Biochem Biophys Res Commun; 2009 Feb; 380(1):5-10. PubMed ID: 19138668
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
